Novo Nordisk (NVO)
(Delayed Data from NYSE)
$136.97 USD
+0.09 (0.07%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $136.93 -0.04 (-0.03%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Earnings News For NVO
-
Novo Nordisk (NVO) Falls as Q2 Earnings and Sales Miss, View Up
-
Novo Nordisk: Q2 Earnings Snapshot
-
Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
-
Novo Nordisk: Q1 Earnings Snapshot
-
Novo Nordisk (NVO) Q4 Earnings Top, GLP-1 Drugs Boost Sales
-
Novo Nordisk: Q4 Earnings Snapshot
-
Novo Nordisk (NVO) to Report Q4 Earnings: What's in the Cards?
-
Novo Nordisk (NVO) Q3 Earnings and Sales Beat, 2023 View Up
-
Novo Nordisk: Q3 Earnings Snapshot
-
Novo Nordisk (NVO) to Report Q3 Earnings: What's in the Cards?
-
Novo Nordisk (NVO) Q2 Earnings and Sales Miss, 2023 View Up
-
Novo Nordisk: Q2 Earnings Snapshot
-
Novo Nordisk (NVO) to Report Q2 Earnings: What's in the Cards?
-
Novo Nordisk (NVO) Q1 Earnings In Line, Sales Miss, View Up
-
Novo Nordisk: Q1 Earnings Snapshot
-
Novo Nordisk (NVO) to Report Q1 Earnings: What's in the Cards?
-
Novo Nordisk (NVO) Q4 Earnings Beat Estimates, Revenues Miss
-
Novo Nordisk: Q4 Earnings Snapshot
-
Is a Beat on the Cards for Novo Nordisk (NVO) in Q4 Earnings?
-
Novo Nordisk's (NVO) Q3 Earnings & Revenues Beat Estimates
-
Novo Nordisk: Q3 Earnings Snapshot
-
Novo Nordisk's (NVO) Q2 Earnings Miss, Sales Beat Estimates
-
Novo Nordisk: Q2 Earnings Snapshot
-
Novo Nordisk (NVO) to Report Q2 Earnings: What's in the Cards?
-
Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates